| BERNSTEIN RESEARCH stuft AIR FRANCE-KLM auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Air France-KLM auf "Market-Perform" mit einem Kursziel von 11,50 Euro belassen. Alex Irving hob in einer am... ► Artikel lesen |
| AAR CORP.: AAR and Air France Industries KLM Engineering & Maintenance complete formation of xCelle Asia joint venture | WOOD DALE, Ill. and PARIS and AMSTELVEEN, Netherlands and CHONBURI, Thailand, Dec. 10, 2025 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial... ► Artikel lesen |
| UBS stuft AIR FRANCE-KLM auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Air France-KLM mit einem Kursziel von 11,05 Euro auf "Neutral" belassen. Insgesamt erwartet Jarrod Castle ein weiteres gutes... ► Artikel lesen |
| Koninklijke Vopak N.V.: Vopak reports strong performance, driven by a resilient portfolio | The Netherlands, 5 November 2025 Vopak reports strong performance, driven by a resilient portfolioKey highlights Improve Net profit -including exceptional items- increased YTD Q3 2025 by 30% to... ► Artikel lesen |
| Koninklijke Vopak N.V.: Ottco and Royal Vopak sign strategic agreement to establish a joint venture in the special economic zone at Duqm | Ottco and Royal Vopak sign strategic agreement to establish a joint venture in the special economic zone at Duqm Muscat, Oman - 27 October 2025 - Oman Tank Terminal Company (OTTCO), a subsidiary... ► Artikel lesen |
| Falcker and Vopak signed an agreement for worldwide deployment of Falcker's advanced tank inspection platform | DELFT, Netherlands, Oct. 8, 2025 /PRNewswire/ -- Inspection and maintenance software specialist, Falcker, and Vopak, the leader in tank storage and infrastructure solutions, have signed... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit | Leiden, the Netherlands, December 8, 2025: Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the Oppenheimer Movers in Rare Disease Summit... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow | Total third quarter 2025 revenues increased by 30% to US$97.3 million, compared to third quarter 2024RUCONEST® third quarter revenue increased by 29% to US$82.2 million, compared to third quarter 2024... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London | Leiden, the Netherlands, October 30, 2025: Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the Jefferies Global Healthcare... ► Artikel lesen |